home / stock / chfs / chfs news


CHFS News and Press, Nuwellis From 12/15/20

Stock Information

Company Name: Nuwellis
Stock Symbol: CHFS
Market: NASDAQ
Website: nuwellis.com

Menu

CHFS CHFS Quote CHFS Short CHFS News CHFS Articles CHFS Message Board
Get CHFS Alerts

News, Short Squeeze, Breakout and More Instantly...

CHFS - CHF Solutions Announces Meta-Analysis Demonstrates Ultrafiltration is Better than Diuretic Therapy for the Management of Volume Overload in ADHF

EDEN PRAIRIE, Minn., Dec. 15, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced a meta-analysis published in Heart Failure Review s concludes that ultrafi...

CHFS - CHF Solutions Announces Webinar on Pediatric Ultrafiltration Therapy hosted by Ladenburg Thalman & Co.

EDEN PRAIRIE, Minn., Dec. 04, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced that Ladenburg Thalman & Co. will host a conference call and webcast at 1:00p.m. Easte...

CHFS - CHF Solutions down 10% on Q3 miss

CHF Solutions ([[CHFS]] -9.1%) Q3 results:Revenue of $1.9M (+52.0% Y/Y) .Net loss: ($4.3M) (+4.4%); loss/share: ($2.08) (+95.9%); Quick Assets: $17.9M.CF Ops: ($13.2M) (-6.7%).The Company hosted two webinars on treatment of fluid overload on pediatric patients and clinical benefits of Aq...

CHFS - CHF Solutions, Inc. (CHFS) CEO John Erb on Q3 2020 Results - Earnings Call Transcript

CHF Solutions, Inc. (CHFS) Q3 2020 Results Conference Call November 10, 2020 09:00 AM ET Company Participants Claudia Drayton - CFO John Erb - Chairman and CEO Nestor Jaramillo - President and COO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Presentation Operator Good morni...

CHFS - CHF Solutions EPS misses by $0.25, misses on revenue

CHF Solutions (CHFS): Q3 GAAP EPS of -$2.08 misses by $0.25.Revenue of $1.9M (+52.0% Y/Y) misses by $0.23M.“CHF Solutions achieved very solid performance in the third quarter, most notably within pediatric accounts. In the third quarter, we had twelve children’s hospitals purcha...

CHFS - CHF Solutions, Inc. Announces 52 Percent Increase in Revenue for Third Quarter 2020 and Provides Company Update

EDEN PRAIRIE, Minn., Nov. 10, 2020 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the third quarter ended September 30, 2020. Recent Highlights Revenue for the third quarter of 2020 was $1.9 million, an increase of 52% compared to the ...

CHFS - CHF Solutions, Inc. To Announce Third Quarter 2020 Financial Results on November 10, 2020

EDEN PRAIRIE, Minn., Nov. 03, 2020 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its third quarter 2020 financial results will be released on Tuesday, November 10, 2020. The company will host a conference call and webcast at 9:00 AM ET that morning, during whic...

CHFS - CHF Solutions Announces First Commercial Shipments of Aquadex Systems to Brazil, following Regulatory Approval

EDEN PRAIRIE, Minn., Oct. 29, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced it has shipped the first commercial orders of its Aquadex SmartFlow™ system to Braz...

CHFS - Mastercard, Akamai Technologies leads premarket losers' pack

Neovasc NVCN -38% as FDA Ad Com thumbs down on Neovasc Reducer.Akerna (KERN) -16%.Six Flags Entertainment SIX -11% on Q3 earnings release.Bed Bath & Beyond BBBY -10% on announcing buyback activity after selling assets.Big 5 Sporting Goods BGFV -9% o...

CHFS - Scholar Rock, Exact Sciences leads healthcare gainers; Catabasis Pharmaceuticals, Galera Therapeutics among major losers

Gainers: Scholar Rock Holding (SRRK) +80%, Exact Sciences (EXAS) +18%, CHF Solutions (CHFS) +17%, CASI Pharmaceuticals (CASI) +13%, Prelude Therapeutics (PRLD) +8%.Losers: Catabasis Pharmaceuticals (CATB) -68%, Galera Therapeutics (GRTX)&...

Previous 10 Next 10